Skip to main content
Top
Published in: Diabetologia 9/2011

01-09-2011 | Article

Design and cohort description of the InterAct Project: an examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes in the EPIC Study

Author: The InterAct Consortium

Published in: Diabetologia | Issue 9/2011

Login to get access

Abstract

Aims/hypothesis

Studying gene–lifestyle interaction may help to identify lifestyle factors that modify genetic susceptibility and uncover genetic loci exerting important subgroup effects. Adequately powered studies with prospective, unbiased, standardised assessment of key behavioural factors for gene–lifestyle studies are lacking. This case–cohort study aims to investigate how genetic and potentially modifiable lifestyle and behavioural factors, particularly diet and physical activity, interact in their influence on the risk of developing type 2 diabetes.

Methods

Incident cases of type 2 diabetes occurring in European Prospective Investigation into Cancer and Nutrition (EPIC) cohorts between 1991 and 2007 from eight of the ten EPIC countries were ascertained and verified. Prentice-weighted Cox regression and random-effects meta-analyses were used to investigate differences in diabetes incidence by age and sex.

Results

A total of 12,403 verified incident cases of type 2 diabetes occurred during 3.99 million person-years of follow-up of 340,234 EPIC participants eligible for InterAct. We defined a centre-stratified subcohort of 16,154 individuals for comparative analyses. Individuals with incident diabetes who were randomly selected into the subcohort (n = 778) were included as cases in the analyses. All prevalent diabetes cases were excluded from the study. InterAct cases were followed-up for an average of 6.9 years; 49.7% were men. Mean baseline age and age at diagnosis were 55.6 and 62.5 years, mean BMI and waist circumference values were 29.4 kg/m2 and 102.7 cm in men, and 30.1 kg/m2 and 92.8 cm in women, respectively. Risk of type 2 diabetes increased linearly with age, with an overall HR of 1.56 (95% CI 1.48–1.64) for a 10 year age difference, adjusted for sex. A male excess in the risk of incident diabetes was consistently observed across all countries, with a pooled HR of 1.51 (95% CI 1.39–1.64), adjusted for age.

Conclusions/interpretation

InterAct is a large, well-powered, prospective study that will inform our understanding of the interplay between genes and lifestyle factors on the risk of type 2 diabetes development.
Appendix
Available only for authorised users
Literature
1.
go back to reference Sladek R, Rocheleau G, Rung J et al (2007) A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 445:881–885PubMedCrossRef Sladek R, Rocheleau G, Rung J et al (2007) A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 445:881–885PubMedCrossRef
2.
go back to reference Saxena R, Voight BF, Lyssenko V et al (2007) Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 316:1331–1336PubMedCrossRef Saxena R, Voight BF, Lyssenko V et al (2007) Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 316:1331–1336PubMedCrossRef
3.
go back to reference Scott LJ, Mohlke KL, Bonnycastle LL, Willer CJ, Li Y, Duren WL et al (2007) A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 316:1341–1345PubMedCrossRef Scott LJ, Mohlke KL, Bonnycastle LL, Willer CJ, Li Y, Duren WL et al (2007) A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 316:1341–1345PubMedCrossRef
4.
go back to reference Zeggini E, Weedon MN, Lindgren CM et al (2007) Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 316:1336–1341PubMedCrossRef Zeggini E, Weedon MN, Lindgren CM et al (2007) Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 316:1336–1341PubMedCrossRef
5.
go back to reference Steinthorsdottir V, Thorleifsson G, Reynisdottir I et al (2007) A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nat Genet 39:770–775PubMedCrossRef Steinthorsdottir V, Thorleifsson G, Reynisdottir I et al (2007) A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nat Genet 39:770–775PubMedCrossRef
6.
go back to reference Zeggini E, Scott LJ, Saxena R et al (2008) Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet 40:638–645PubMedCrossRef Zeggini E, Scott LJ, Saxena R et al (2008) Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet 40:638–645PubMedCrossRef
9.
go back to reference Bingham S, Riboli E (2004) Diet and cancer—the European Prospective Investigation into Cancer and Nutrition. Nat Rev Cancer 4:206–215PubMedCrossRef Bingham S, Riboli E (2004) Diet and cancer—the European Prospective Investigation into Cancer and Nutrition. Nat Rev Cancer 4:206–215PubMedCrossRef
10.
go back to reference Riboli E, Hunt KJ, Slimani N et al (2002) European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr 5:1113–1124PubMedCrossRef Riboli E, Hunt KJ, Slimani N et al (2002) European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr 5:1113–1124PubMedCrossRef
11.
go back to reference Slimani N, Deharveng G, CharrondiFre RU et al (1999) Structure of the standardized computerized 24-h diet recall interview used as reference method in the 22 centers participating in the EPIC project. Comput Meth Programs Biomed 58:251–266CrossRef Slimani N, Deharveng G, CharrondiFre RU et al (1999) Structure of the standardized computerized 24-h diet recall interview used as reference method in the 22 centers participating in the EPIC project. Comput Meth Programs Biomed 58:251–266CrossRef
12.
go back to reference Day N, Oakes S, Luben R et al (1999) EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer. Br J Cancer 80(Suppl 1):95–103PubMed Day N, Oakes S, Luben R et al (1999) EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer. Br J Cancer 80(Suppl 1):95–103PubMed
13.
go back to reference Wareham NJ, Jakes RW, Rennie KL et al (2003) Validity and repeatability of a simple index derived from the short physical activity questionnaire used in the European Prospective Investigation into Cancer and Nutrition (EPIC) Study. Public Health Nutr 6:407–413PubMedCrossRef Wareham NJ, Jakes RW, Rennie KL et al (2003) Validity and repeatability of a simple index derived from the short physical activity questionnaire used in the European Prospective Investigation into Cancer and Nutrition (EPIC) Study. Public Health Nutr 6:407–413PubMedCrossRef
14.
go back to reference Brage S, Ekelund U, Brage N et al (2007) Hierarchy of individual calibration levels for heart rate and accelerometry to measure physical activity. J Appl Physiol 103:682–692PubMedCrossRef Brage S, Ekelund U, Brage N et al (2007) Hierarchy of individual calibration levels for heart rate and accelerometry to measure physical activity. J Appl Physiol 103:682–692PubMedCrossRef
15.
go back to reference Martyn CN, Barker DJ, Osmond C (1996) Mothers’ pelvic size, fetal growth, and death from stroke and coronary heart disease in men in the UK. Lancet 348:1264–1268PubMedCrossRef Martyn CN, Barker DJ, Osmond C (1996) Mothers’ pelvic size, fetal growth, and death from stroke and coronary heart disease in men in the UK. Lancet 348:1264–1268PubMedCrossRef
16.
go back to reference Pischon T, Boeing H, Hoffmann K et al (2008) General and abdominal adiposity and risk of death in Europe. N Engl J Med 359:2105–2120PubMedCrossRef Pischon T, Boeing H, Hoffmann K et al (2008) General and abdominal adiposity and risk of death in Europe. N Engl J Med 359:2105–2120PubMedCrossRef
17.
go back to reference McCarthy MI, Hirschhorn JN (2008) Genome-wide association studies: potential next steps on a genetic journey. Hum Mol Genet 17:R156–R165PubMedCrossRef McCarthy MI, Hirschhorn JN (2008) Genome-wide association studies: potential next steps on a genetic journey. Hum Mol Genet 17:R156–R165PubMedCrossRef
18.
go back to reference McCarthy MI, Zeggini E (2009) Genome-wide association studies in type 2 diabetes. Curr Diab Rep 9:164–171PubMedCrossRef McCarthy MI, Zeggini E (2009) Genome-wide association studies in type 2 diabetes. Curr Diab Rep 9:164–171PubMedCrossRef
19.
go back to reference Timpson NJ, Lindgren CM, Weedon MN et al (2009) Adiposity-related heterogeneity in patterns of type 2 diabetes susceptibility observed in genome-wide association data. Diabetes 58:505–510PubMedCrossRef Timpson NJ, Lindgren CM, Weedon MN et al (2009) Adiposity-related heterogeneity in patterns of type 2 diabetes susceptibility observed in genome-wide association data. Diabetes 58:505–510PubMedCrossRef
20.
go back to reference Florez JC, Jablonski KA, Bayley N et al (2006) TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. N Engl J Med 355:241–250PubMedCrossRef Florez JC, Jablonski KA, Bayley N et al (2006) TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. N Engl J Med 355:241–250PubMedCrossRef
21.
go back to reference Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047–1053PubMedCrossRef Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047–1053PubMedCrossRef
22.
go back to reference Shaw JE, Sicree RA, Zimmet PZ (2010) Global estimates of the prevalence of diabetes for 2010 and 2030. Diab Res Clin Pract 87:4–14CrossRef Shaw JE, Sicree RA, Zimmet PZ (2010) Global estimates of the prevalence of diabetes for 2010 and 2030. Diab Res Clin Pract 87:4–14CrossRef
23.
go back to reference Jansson SP, Andersson DK, Svardsudd K (2007) Prevalence and incidence rate of diabetes mellitus in a Swedish community during 30 years of follow-up. Diabetologia 50:703–710PubMedCrossRef Jansson SP, Andersson DK, Svardsudd K (2007) Prevalence and incidence rate of diabetes mellitus in a Swedish community during 30 years of follow-up. Diabetologia 50:703–710PubMedCrossRef
24.
go back to reference Soriguer F, Rojo-Martinez G, Almaraz MC et al (2008) Incidence of type 2 diabetes in southern Spain (Pizarra Study). Eur J Clin Invest 38:126–133PubMedCrossRef Soriguer F, Rojo-Martinez G, Almaraz MC et al (2008) Incidence of type 2 diabetes in southern Spain (Pizarra Study). Eur J Clin Invest 38:126–133PubMedCrossRef
25.
go back to reference Forouhi NG, Luan J, Hennings S, Wareham NJ (2007) Incidence of type 2 diabetes in England and its association with baseline impaired fasting glucose: the Ely Study 1990–2000. Diabet Med 24:200–207PubMedCrossRef Forouhi NG, Luan J, Hennings S, Wareham NJ (2007) Incidence of type 2 diabetes in England and its association with baseline impaired fasting glucose: the Ely Study 1990–2000. Diabet Med 24:200–207PubMedCrossRef
26.
go back to reference Rathmann W, Strassburger K, Heier M, Holle R, Thorand B, Giani G et al (2009) Incidence of type 2 diabetes in the elderly German population and the effect of clinical and lifestyle risk factors: KORA S4/F4 cohort study. Diabet Med 26:1212–1219PubMedCrossRef Rathmann W, Strassburger K, Heier M, Holle R, Thorand B, Giani G et al (2009) Incidence of type 2 diabetes in the elderly German population and the effect of clinical and lifestyle risk factors: KORA S4/F4 cohort study. Diabet Med 26:1212–1219PubMedCrossRef
27.
go back to reference Bonora E, Kiechl S, Willeit J et al (2004) Population-based incidence rates and risk factors for type 2 diabetes in white individuals: the Bruneck Study. Diabetes 53:1782–1789PubMedCrossRef Bonora E, Kiechl S, Willeit J et al (2004) Population-based incidence rates and risk factors for type 2 diabetes in white individuals: the Bruneck Study. Diabetes 53:1782–1789PubMedCrossRef
28.
go back to reference Arteagoitia JM, Larranaga MI, Rodriguez JL, Fernandez I, Pinies JA (2003) Incidence, prevalence and coronary heart disease risk level in known type 2 diabetes: a sentinel practice network study in the Basque Country, Spain. Diabetologia 46:899–909PubMedCrossRef Arteagoitia JM, Larranaga MI, Rodriguez JL, Fernandez I, Pinies JA (2003) Incidence, prevalence and coronary heart disease risk level in known type 2 diabetes: a sentinel practice network study in the Basque Country, Spain. Diabetologia 46:899–909PubMedCrossRef
29.
go back to reference Valdes S, Botas P, Delgado E, Alvarez F, Cadorniga FD (2007) Population-based incidence of type 2 diabetes in northern Spain: the Asturias Study. Diabetes Care 30:2258–2263PubMedCrossRef Valdes S, Botas P, Delgado E, Alvarez F, Cadorniga FD (2007) Population-based incidence of type 2 diabetes in northern Spain: the Asturias Study. Diabetes Care 30:2258–2263PubMedCrossRef
30.
go back to reference Meisinger C, Thorand B, Schneider A, Stieber J, Doring A, Lowel H (2002) Sex differences in risk factors for incident type 2 diabetes mellitus: the MONICA Augsburg cohort study. Arch Intern Med 162:82–89PubMedCrossRef Meisinger C, Thorand B, Schneider A, Stieber J, Doring A, Lowel H (2002) Sex differences in risk factors for incident type 2 diabetes mellitus: the MONICA Augsburg cohort study. Arch Intern Med 162:82–89PubMedCrossRef
31.
go back to reference Hippisley-Cox J, Coupland C, Robson J, Sheikh A, Brindle P (2009) Predicting risk of type 2 diabetes in England and Wales: prospective derivation and validation of QDScore. BMJ 338:b880PubMedCrossRef Hippisley-Cox J, Coupland C, Robson J, Sheikh A, Brindle P (2009) Predicting risk of type 2 diabetes in England and Wales: prospective derivation and validation of QDScore. BMJ 338:b880PubMedCrossRef
32.
go back to reference Marteau TM, French DP, Griffin SJ et al. (2010) Effects of communicating DNA-based disease risk estimates on risk-reducing behaviours. Cochrane Database of Systematic Reviews 2010, Issue 10, Art. no.: CD007275. doi:10.1002/14651858.CD007275.pub2. Marteau TM, French DP, Griffin SJ et al. (2010) Effects of communicating DNA-based disease risk estimates on risk-reducing behaviours. Cochrane Database of Systematic Reviews 2010, Issue 10, Art. no.: CD007275. doi:10.​1002/​14651858.​CD007275.​pub2.
Metadata
Title
Design and cohort description of the InterAct Project: an examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes in the EPIC Study
Author
The InterAct Consortium
Publication date
01-09-2011
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 9/2011
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-011-2182-9

Other articles of this Issue 9/2011

Diabetologia 9/2011 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.